Depression and suicide in adults have become significant public health issues in China and globally, imposing a heavy burden on patients and society. In 2023, the United States Preventive Services Task Force (USPSTF) published a recommendation statement on Screening for Depression and Suicide Risk in Adults in JAMA. The statement suggested screening for depression in adults, including pregnant and postpartum individuals, as well as the elderly. However, the evidence regarding the risks and benefits of suicide screening is insufficient, making it challenging to determine its overall impact. This article provides an overview of adult depression and suicide, including epidemiology, risk factors, early screening tools, pros and cons, treatments and interventions, and the guidance value of the USPSTF statement for general practitioners, combining insights from the USPSTF statement and current research both domestically and internationally.
